Chief Executive Officer

Senior Vice President Business Process and IT

Aquestive Therapeutics Insider Sold Shares Worth $473,701, According to a Recent SEC Filing

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™

Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film

Aquestive Therapeutics issued two additional U.S. patents to Anaphylm

Vice President, Sales

Aquestive Therapeutics is a company focused on commercializing innovative therapeutics, and they are seeking a Vice President of Sales to lead the commercial launch of Anaphylm® for severe allergic reactions. This role involves building a high-performing sales team, executing sales strategies, and ensuring compliance with healthcare regulations.

Sign up with Google

Sign in with Google